Novavax (NVAX) Non-Current Debt (2010 - 2015)

Novavax (NVAX) recorded quarterly Non-Current Debt of $45000.0 in Q3 2015, down 69.8% quarter-over-quarter from $149000.0 in Q2 2015.

Novavax (NVAX) Non-Current Debt (2010 - 2015) Analysis & Trends

Novavax's Non-Current Debt history runs 6 years deep, the most recent figure standing at $45000.0 for Q3 2015.

  • In Q3 2015, Non-Current Debt changed N/A year-over-year to $45000.0; the TTM figure through Sep 2015 stood at $45000.0 (changed N/A YoY), while the FY2014 annual figure was $395000.0, down 60.66% from the prior year.
  • Non-Current Debt was $45000.0 for Q3 2015 at Novavax, down from $149000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.7 million in Q2 2013 to a low of $45000.0 in Q3 2015.
  • Historically, Non-Current Debt has averaged $659250.0 across 5 years, with a median of $400000.0 in 2012.
  • The sharpest annual moves came in 2013 and 2015: Non-Current Debt jumped 313.25% in 2013, then slumped 70.73% in 2015.
  • A 5-year view of Non-Current Debt shows it stood at $300000.0 in 2011, then surged by 151.0% to $753000.0 in 2012, then surged by 33.33% to $1.0 million in 2013, then plunged by 60.66% to $395000.0 in 2014, then plunged by 88.61% to $45000.0 in 2015.
  • The last three Non-Current Debt figures came in at $45000.0 (Q3 2015), $149000.0 (Q2 2015), and $252000.0 (Q1 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Novavax 1.49 Bn 931.98 Mn 108.82 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 45,000.00
Sep 30, 2015 45,000.00
Jun 30, 2015 149,000.00
Jun 30, 2015 149,000.00
Mar 31, 2015 252,000.00
Mar 31, 2015 252,000.00
Dec 31, 2014 395,000.00
Dec 31, 2014 395,000.00
Mar 31, 2014 861,000.00
Mar 31, 2014 861,000.00
Dec 31, 2013 1.00 Mn
Dec 31, 2013 1.00 Mn
Sep 30, 2013 1.65 Mn
Sep 30, 2013 1.65 Mn
Jun 30, 2013 1.65 Mn
Jun 30, 2013 1.65 Mn
Mar 31, 2013 1.29 Mn
Mar 31, 2013 1.29 Mn
Dec 31, 2012 753,000.00
Dec 31, 2012 753,000.00